ACP Letter of Support for the Protecting Patients from Deceptive Drug Ads Online Act

ACP expresses support for legislation that would tackle the explosion of misleading promotions by new entities, including social media influencers and telehealth companies, that are generally not subject to existing FDA prescription drug information and disclosure requirements.

Robin Chichester

Durbin; Braun; Protecting Patients from Deceptive Drug Ads Online Act; social media influencers; deceptive ads; DTC advertising; direct-to-consumer; prescription drug ads; FDA; drug side effects and advertising; drug requirements; pharmacuetical regulation

Wed, 08/28/2024 - 10:36 AM EDT

Wed, 08/28/2024 - 11:07 AM EDT

2

acp_letter_of_support_for_protecting_patients_from_deceptive_drug_ads_online_act_2024.pdf

{"Author":"Robin Chichester","CreationDate":"2024-08-28T07:36:48-07:00","Creator":"Microsoft Word","Keywords":"Durbin; Braun; Protecting Patients from Deceptive Drug Ads Online Act; social media influencers; deceptive ads; DTC advertising; direct-to-consumer; prescription drug ads; FDA; drug side effects and advertising; drug requirements; pharmacuetical regulation","ModDate":"2024-08-28T11:07:11-04:00","Title":"ACP Letter of Support for the Protecting Patients from Deceptive Drug Ads Online Act","Pages":2,"dc:format":"application\/pdf","dc:creator":"Robin Chichester","dc:title":"ACP Letter of Support for the Protecting Patients from Deceptive Drug Ads Online Act","dc:subject":["Durbin","Braun","Protecting Patients from Deceptive Drug Ads Online Act","social media influencers","deceptive ads","DTC advertising","direct-to-consumer","prescription drug ads","FDA","drug side effects and advertising","drug requirements","pharmacuetical regulation"],"xmp:creatortool":"Microsoft Word","xmp:createdate":"2024-08-28T07:36:48-07:00","xmp:modifydate":"2024-08-28T11:07:11-04:00","xmp:metadatadate":"2024-08-28T11:07:11-04:00","xmpmm:documentid":"uuid:15E43EAD-A7AE-4A0B-890F-7505016EC592","xmpmm:instanceid":"uuid:d96257ff-8595-4d47-80f9-a16c6624f8b6","pdf:keywords":"Durbin; Braun; Protecting Patients from Deceptive Drug Ads Online Act; social media influencers; deceptive ads; DTC advertising; direct-to-consumer; prescription drug ads; FDA; drug side effects and advertising; drug requirements; pharmacuetical regulation"}

2024